Trials / Conditions / Staphylococcus Aureus Septicemia
Staphylococcus Aureus Septicemia
5 registered clinical trials studyying Staphylococcus Aureus Septicemia — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia NCT06650501 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 4 |
| Recruiting | Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia NCT06650488 | Todd C. Lee MD MPH FIDSA | Phase 4 |
| Recruiting | Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia NCT06637332 | Todd C. Lee MD MPH FIDSA | Phase 4 |
| Recruiting | Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia NCT04886284 | Todd C. Lee MD MPH FIDSA | Phase 2 |
| Not Yet Recruiting | 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia NCT05361135 | University College, London | N/A |